9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways

Published:2009-01-12 Issue:8 Volume:28 Page:1151-1161
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Guo C,Gasparian A V,Zhuang Z,Bosykh D A,Komar A A,Gudkov A V,Gurova K V

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2008460.pdf

Reference29 articles.

1. Bensaad K, Vousden KH . (2005). Savior and slayer: the two faces of p53. Nat Med 11: 1278–1279.

2. Budanov AV, Karin M . (2008). p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451–460.

3. Camps M, Rückle T, Ji H, Ardissone V, Rintelen F, Shaw J et al. (2005). Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11: 936–943.

4. Furuta M, Weil RJ, Vortmeyer AO, Huang S, Lei J, Huang TN et al. (2004). Protein patterns and proteins that identify subtypes of glioblastoma multiforme. Oncogene 23: 6806–6814.

5. Feng Z, Zhang H, Levine AJ, Jin S . (2005). The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102: 8204–8209.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–activity relationship investigations probing the cytotoxicity of 9‐aminoacridine derivatives with PC3 and A549;Journal of Heterocyclic Chemistry;2024-07-09

2. Influence of N-protonation on electronic properties of acridine derivatives by quantum crystallography;RSC Advances;2024

3. Developing novel antimicrobials by combining cancer chemotherapeutics with bacterial DNA repair inhibitors;PLOS Pathogens;2023-12-07

4. Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300;Medical Oncology;2023-11-08

5. The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients;npj Precision Oncology;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3